Accendra Health (ACH) Fundamental Analysis: Revenue, Earnings & Valuation

9.92 / 10

Outperform

Fundamentally, ACH scores 9.9/10 with an Outperform rating. Key strengths are PB‑ROE and Cash‑MV, delivering high quality scores, while Asset‑MV and Revenue‑MV lag. Total profit growth is solid (group 3), but earnings per share growth is weak, pulling the overall picture toward strong fundamentals.

Analysis Checks(3/10)

Revenue-MV

Value2.90

Score1/3

Weight174.10%

1M Return3.16%

Net cash flow from operating activities per share (YoY growth rate %)

Value-163.70

Score0/3

Weight-125.57%

1M Return-3.08%

PB-ROE

Value-0.97

Score2/3

Weight45.02%

1M Return0.81%

Basic earnings per share (YoY growth rate %)

Value-202.54

Score0/3

Weight-75.84%

1M Return-1.82%

Total profit (YoY growth rate %)

Value69.09

Score2/3

Weight102.82%

1M Return1.87%

Net cash flow from operating activities (YoY growth rate %)

Value-163.03

Score0/3

Weight-122.84%

1M Return-2.92%

Cash-UP

Value-0.15

Score0/3

Weight-210.54%

1M Return-4.87%

Diluted earnings per share (YoY growth rate %)

Value-202.54

Score0/3

Weight-72.78%

1M Return-1.72%

Asset-MV

Value-0.55

Score0/3

Weight-45.88%

1M Return-0.96%

Cash-MV

Value2.01

Score3/3

Weight431.51%

1M Return6.61%

Is ACH fundamentally strong?

ACH scores 9.92/10 on fundamentals and holds a Discounted valuation at present. Backed by its -1755.61% ROE, -39.85% net margin, -0.17 P/E ratio, -0.41 P/B ratio, and -202.54% earnings growth, these metrics solidify its Outperform investment rating.